铋剂、莫西沙星、四环素、兰索拉唑四联一线疗法根除幽门螺杆菌：一项前瞻性研究。 - Suppr

Suppr

超能文献

Bismuth, moxifloxacin, tetracycline, lansoprazole quadruple first line therapy for eradication of H. pylori: A prospective study.

作者信息

Ergül Bilal, Koçak Erdem, Taş Adnan, Filik Levent, Köklü Seyfettin

机构信息

Ankara Education and Research Hospital, Gastroenterology, Ankara, Turkey.

出版信息

Clin Res Hepatol Gastroenterol. 2013 Nov;37(5):527-9. doi: 10.1016/j.clinre.2012.10.014. Epub 2013 Jan 9.

DOI:10.1016/j.clinre.2012.10.014

PMID:23312494

Abstract

摘要

相似文献

Bismuth, moxifloxacin, tetracycline, lansoprazole quadruple first line therapy for eradication of H. pylori: A prospective study.铋剂、莫西沙星、四环素、兰索拉唑四联一线疗法根除幽门螺杆菌：一项前瞻性研究。

Clin Res Hepatol Gastroenterol. 2013 Nov;37(5):527-9. doi: 10.1016/j.clinre.2012.10.014. Epub 2013 Jan 9.

Efficacy of moxifloxacin-based triple therapy as second-line treatment for Helicobacter pylori infection.基于莫西沙星的三联疗法作为幽门螺杆菌感染二线治疗的疗效。

Helicobacter. 2006 Feb;11(1):46-51. doi: 10.1111/j.0083-8703.2006.00371.x.

Second-line treatment for Helicobacter pylori infection: 10-day moxifloxacin-based triple therapy versus 2-week quadruple therapy.幽门螺杆菌感染的二线治疗：基于莫西沙星的10天三联疗法与2周四联疗法对比

Helicobacter. 2007 Dec;12(6):623-8. doi: 10.1111/j.1523-5378.2007.00548.x.

Comparison of three different second-line quadruple therapies including bismuth subcitrate in Turkish patients with non-ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14-day standard first-line therapy.在土耳其非溃疡性消化不良患者中，比较三种不同的含枸橼酸铋钾二线四联疗法，这些患者采用14天标准一线疗法未能根除幽门螺杆菌。

J Gastroenterol Hepatol. 2008 Jan;23(1):42-5. doi: 10.1111/j.1440-1746.2007.04984.x. Epub 2007 Jun 7.

The efficacy of two-week quadruple first-line therapy with bismuth, lansoprazole, amoxicillin, clarithromycin on Helicobacter pylori eradication: a prospective study.两周铋剂四联一线疗法根除幽门螺杆菌的疗效：一项前瞻性研究。

Helicobacter. 2013 Dec;18(6):454-8. doi: 10.1111/hel.12086. Epub 2013 Sep 9.

Moxifloxacin-tetracycline-lansoprazole triple therapy for first-line treatment of Helicobacter pylori infection: a prospective study.莫西沙星-四环素-兰索拉唑三联疗法作为幽门螺杆菌感染的一线治疗：一项前瞻性研究。

Helicobacter. 2011 Feb;16(1):52-4. doi: 10.1111/j.1523-5378.2010.00817.x.

How to Effectively Use Bismuth Quadruple Therapy: The Good, the Bad, and the Ugly.如何有效使用铋剂四联疗法：优点、缺点与问题

Gastroenterol Clin North Am. 2015 Sep;44(3):537-63. doi: 10.1016/j.gtc.2015.05.003. Epub 2015 Jun 19.

Effectiveness and safety of repeated quadruple therapy in Helicobacter pylori infection after failure of second-line quadruple therapy: repeated quadruple therapy as a third-line therapy.二线四联疗法失败后重复四联疗法治疗幽门螺杆菌感染的疗效和安全性：重复四联疗法作为三线疗法。

Helicobacter. 2011 Oct;16(5):410-4. doi: 10.1111/j.1523-5378.2011.00870.x.

4-day lansoprazole quadruple therapy: a highly effective cure for Helicobacter pylori infection.4天的兰索拉唑四联疗法：幽门螺杆菌感染的高效治愈方法。

Am J Gastroenterol. 1996 Sep;91(9):1778-82.

Moxifloxacin-containing triple therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate.含莫西沙星的三联疗法作为幽门螺杆菌感染的二线治疗：治疗疗程和抗生素耐药性对根除率的影响。

Helicobacter. 2009 Oct;14(5):77-85. doi: 10.1111/j.1523-5378.2009.00709.x.

引用本文的文献

Structural Insights into New Bi(III) Coordination Polymers with Pyridine-2,3-Dicarboxylic Acid: Photoluminescence Properties and Anti- Activity.新型 Bi(III) 配合物与吡啶-2,3-二羧酸的结构研究：荧光性质和抗活性。

Int J Mol Sci. 2020 Nov 18;21(22):8696. doi: 10.3390/ijms21228696.

Adding Bismuth to Rabeprazole-Based First-Line Triple Therapy Does Not Improve the Eradication of .在基于雷贝拉唑的一线三联疗法中添加铋剂并不能提高……的根除率。

Gastroenterol Res Pract. 2017;2017:5320180. doi: 10.1155/2017/5320180. Epub 2017 Jul 16.

Pharmacological therapy used in the elimination of Helicobacter pylori infection: a review.用于根除幽门螺杆菌感染的药物治疗：综述

World J Gastroenterol. 2015 Jan 7;21(1):139-54. doi: 10.3748/wjg.v21.i1.139.

Metal complexes of quinolone antibiotics and their applications: an update.喹诺酮类抗生素的金属配合物及其应用：最新进展。

Molecules. 2013 Sep 11;18(9):11153-97. doi: 10.3390/molecules180911153.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验